WELCOME TO SIT ITALIA

copertina SIT Press Release

Sit Acquires Natifar And Natimed From Laboratorios Bial

SIT Group is pleased to announce the acquisition of Natifar and Natimed brands from Laboratorios BIAL, a Spanish affiliate of BIAL Group (BIAL), as a result of the agreement signed on October 25th, 2022. 

Either products will be distributed by DESMA Spain, which already include in its Spanish portfolio well-known brands in different therapeutic areas like Akineton, Hemicraneal and Proctolog. 

SIT PHARMA is pleased to announce the acquisition of OSTIDIL-D3 and KEFORAL
SIT Pharma is pleased to announce the acquisition of DERINOX® from Therabel Lucien Pharma Sas
SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED